Detalles de la búsqueda
1.
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
Br J Cancer
; 127(3): 383-393, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35264788
2.
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
Oncologist
; 27(6): e484-e493, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429394
3.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462870
4.
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
Oncologist
; 25(12): e1996-e2005, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32557976
5.
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.
Br J Cancer
; 120(5): 522-526, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30745584
6.
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer.
Br J Cancer
; 121(7): 593-599, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474758
7.
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors.
Oncologist
; 24(8): 1128-1136, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31015312
8.
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).
Oncologist
; 24(6): e318-e326, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30846513
9.
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.
Br J Cancer
; 114(1): 30-6, 2016 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26575603
10.
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports.
Front Oncol
; 14: 1363069, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38529368
11.
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis.
Front Immunol
; 15: 1353889, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38322260
12.
Aumolertinib in NSCLC with leptomeningeal involvement, harbouring concurrent EGFR exon 19 deletion and TP53 comutation: a case report.
J Thorac Dis
; 15(7): 4016-4026, 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37559636
13.
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
EClinicalMedicine
; 61: 102044, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434748
14.
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs.
Front Oncol
; 12: 840783, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35494084
15.
Home-Based Management of Patients With Cancer Experiencing Treatment-Induced Toxicities With a Nurse-Led Telephone Triage (the NTT Study).
JCO Oncol Pract
; 18(1): e20-e27, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34242052
16.
Comparing immunotherapies to other frequently used treatments of gastric cancer.
Expert Rev Clin Pharmacol
; 14(10): 1221-1232, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34114518
17.
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome.
Transl Lung Cancer Res
; 10(1): 202-220, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33569305
18.
Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis.
Eur J Cancer
; 146: 145-154, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33607478
19.
Case Report: A Metabolic Complete Response to Upfront Osimertinib in a Smoker Non-Small Cell Lung Cancer Patient Harbouring EGFR G719A/V769M Complex Mutation.
Onco Targets Ther
; 13: 12027-12031, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33262603
20.
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study.
Adv Ther
; 37(3): 1145-1155, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32002809